U.S. Consumer Durables Stock News

Ames National (ATLO) has just wrapped up FY 2025 with fourth quarter revenue of US$19.3 million and EPS of US$0.73, capping a trailing twelve month run of US$65.8 million in revenue and EPS of US$2.14 that coincides with 86.2% earnings growth and a net profit margin of 28.9% over the last year. The company has seen revenue move from US$53.5 million and EPS of US$1.14 on a trailing basis at the end of 2024 to the latest trailing totals, which may help provide a clearer picture of earnings...

Perrigo, a major holding in the Invesco High Yield Dividend ETF (PEY), has recently come under scrutiny as it pays out more in dividends than it earns, reflecting pressures from weaker business performance. This mismatch between earnings and dividends raises a material question for income-focused investors: how reliable is Perrigo’s payout policy over time? We’ll now examine how concerns about Perrigo’s dividend sustainability shape its broader investment narrative for current and...

Gold Resource (GORO) is back in focus after a temporary work stoppage at its Don David mine in Oaxaca, driven by an illegal access blockade linked to a dispute among contractor affiliated union factions. See our latest analysis for Gold Resource. The recent contractor blockade comes after a period of strong share price momentum, with a 90 day share price return of 115.85% and a 1 year total shareholder return of 234.72%. However, the 5 year total shareholder return of a 40.59% decline shows...

PROCEPT BioRobotics has drawn increased attention for its AquaBeam Robotic System for benign prostatic hyperplasia, as investors react to past and upcoming regulatory and clinical milestones that were seen as potentially meaningful for the technology’s medical adoption prospects. An interesting angle is how options trading around these anticipated approvals and trial readouts has become a focal point for investors seeking to position around milestone-driven volatility. We’ll now examine how...

Recent performance snapshot OGE Energy (OGE) has moved quietly on the screens recently, with the stock slipping about 1.1% over the past day and 2.2% over the past week, keeping interest on its underlying fundamentals. Over the past month the share price has been broadly flat, while the past 3 months show an 8.2% decline. This backdrop may prompt you to compare recent returns with the company’s longer term profile. See our latest analysis for OGE Energy. Looking beyond the latest moves, OGE...

Affinity Bancshares (AFBI) has reported solid headline numbers for FY 2025 so far, with third quarter total revenue of US$8.3 million and basic EPS of US$0.35, supported by trailing twelve month revenue of US$31.8 million and EPS of US$1.19. Across the last few reported quarters, revenue has moved from US$7.4 million in Q4 2024 to US$7.8 million in Q1 2025, US$8.3 million in Q2 2025 and US$8.3 million in Q3 2025. Over the same stretch, quarterly EPS has gone from US$0.21 to US$0.29, US$0.34...

SEALSQ Corp and WISeKey’s subsidiary recently signed a non-binding Memorandum of Understanding with the Government of Gujarat and Kaynes SemiCon to collaborate on establishing India’s first secure semiconductor design, test, and personalization center focused on post-quantum cryptography at Sanand, targeting capacity of up to 300 million secure chips annually. This planned joint venture, SEALKAYNESQ Ltd, is intended to support India’s onshore, quantum‑resistant semiconductor ecosystem for...

DigitalBridge Group (NYSE:DBRG) has agreed to be acquired by SoftBank for a cash consideration. The deal has triggered third party investigations into whether shareholders are receiving adequate compensation. Questions have also been raised about disclosures around the transaction and the absence of competing bids. DigitalBridge Group focuses on digital infrastructure assets, an area that sits at the intersection of data centers, networking and communications. The decision by SoftBank to...

If you are wondering whether FTAI Aviation's current share price lines up with its fundamentals, you are not alone. Many investors are asking the same question right now. The stock last closed at US$292.10, with returns of 6.7% over 7 days, 67.7% over 30 days, 38.9% year to date and 224.2% over 1 year, with the 3 year and 5 year returns both very large. Recent coverage around FTAI Aviation has focused on how its business model fits into broader themes in the aviation and leasing industry, as...

Revolution Medicines (NasdaqGS:RVMD) has attracted reported takeover interest from Merck, drawing fresh attention to the company and its pipeline. The interest surfaces as Revolution Medicines insiders, including General Counsel Jeff Cislini, have recently sold shares. Investors are weighing potential M&A activity alongside insider transactions and a sharply higher share price. Revolution Medicines enters this phase with strong recent share price moves, with the stock at $117.63 and up...

In recent weeks, Progyny received a series of analyst upgrades after meetings with management highlighted strong demand for its fertility benefits platform, improved earnings visibility, and nearly complete client retention heading into 2026. Analysts also emphasized Progyny’s breadth of over 600 employer clients and the absence of any single customer contributing more than 5% of revenue, underlining the resilience of its business model. Next, we’ll examine how this combination of...

Institutional investor commentaries highlight shifting sentiment on Doximity (NYSE:DOCS) following its latest quarterly results and outlook. The stock has faced pressure after cautious company guidance and recent healthcare policy changes. Hedge fund ownership has modestly increased, pointing to continued institutional interest despite recent share price moves. Doximity continues to focus on physician engagement, telehealth, and workflow tools as it responds to a rapidly changing digital...

If you are wondering whether Pursuit Attractions and Hospitality is offering fair value at its recent price, this article walks through the numbers in a straightforward way so you can judge for yourself. The stock recently closed at US$35.25, with returns of 5.3% over the last 7 days, 2.9% over 30 days, 5.5% year to date, 22.8% over 3 years and a 9.1% decline over 1 year, which gives a mixed picture of recent and longer term performance. Outside of regular trading updates, investors have...

If you are wondering whether STAAR Surgical's share price reflects its true value today, it helps to step back and look at how the market has been treating the stock recently. Over the last week, the share price return was 8.7% lower. The 30 day, year to date and 1 year returns were 18.0%, 18.9% and 21.7% lower respectively, and the 3 year and 5 year returns were 73.4% and 81.3% lower. This gives important context before judging any potential upside or downside. Recent coverage around STAAR...

CSX (NasdaqGS:CSX) is cutting 166 management roles and furloughing nearly 200 conductors as part of a broad operational restructuring. The company is responding to persistent freight market challenges that have affected its latest quarterly results. New CEO Steve Angel is prioritizing productivity efforts, technology spending, and streamlined operations to manage costs. CSX operates one of the major freight rail networks in the US, serving industrial, agricultural, and consumer end markets...

If you are asking whether NCR Atleos at US$37.63 is a bargain, fully priced, or something in between, this article is going to walk you through the key signals that matter for valuation. The stock has moved around recently, with a 5.8% decline over the last 7 days, a 3.5% decline over the last 30 days, and returns of 1.1% year to date and 15.7% over the last year. Recent coverage has focused on NCR Atleos as a stand alone ATM and financial technology infrastructure business following its...

Riverwater Partners Sustainable Value Strategy has initiated a new position in Adeia Inc. (NasdaqGS:ADEA). The position reflects fresh institutional interest in Adeia's intellectual property business across media and semiconductor markets. Adeia focuses on licensing intellectual property that underpins media content distribution and semiconductor design, areas that remain central to how video is delivered and how chips are structured and manufactured. As streaming, connected devices and...

Omnicell, ticker NasdaqGS:OMCL, has expanded its digital healthcare focus with new medication management solutions. The company has launched its XT Amplify program, aimed at supporting hospitals and health systems with medication management. These moves highlight Omnicell's efforts to align its portfolio with outcome focused digital healthcare trends. At a share price of $50.3, Omnicell is coming off a mixed return profile, with the stock up 8.4% over the past 30 days and 11.4% year to...

Arbe Robotics (ARBE) is attracting fresh attention after a sharp move in both its shares and options, with recent trading sessions showing concentrated call option activity and heavier volumes than the average month. See our latest analysis for Arbe Robotics. The latest options activity comes after a volatile stretch where the 7 day share price return of 49.12% and 30 day share price return of 65.05% contrast with a 1 year total shareholder return loss of 43.14%. This suggests short term...

UFC has signed a multi year exclusive media rights agreement with FPT Play to broadcast UFC events in Vietnam. The deal gives FPT Play exclusive rights to distribute UFC content to viewers across Vietnam. For TKO Group Holdings (NYSE:TKO), which owns UFC, this agreement adds another piece to its international media footprint. UFC already has a global fan base, and Vietnam is a market with growing interest in combat sports and digital streaming. Partnering with an exclusive local distributor...

If you are wondering whether McKesson at around US$820 a share is still reasonably priced or starting to look expensive, you are in the right place. The stock has eased back recently, with a 2.4% decline over the last week and a 0.8% decline over the last month, although the 1 year return sits at 39.2% and the 3 year return at 119.5%. Recent coverage has focused on McKesson as one of the large distributors at the heart of the U.S. healthcare supply chain. This keeps it in the spotlight...

If you are wondering whether Moody's current share price still makes sense after a strong multi year run, this article will walk through what that price might imply about the company. Moody's closed at US$524.04, with a 2.8% decline over the last 7 days, a 1.3% gain over 30 days, a 5.0% gain year to date, a 7.8% gain over 1 year, a 68.1% gain over 3 years and a 105.2% gain over 5 years. Recent moves in the stock sit against an ongoing demand backdrop for credit ratings and analytics, as...

If you are wondering whether Interparfums at around US$98.76 is attractively priced or asking too much for its brand power, you are in the right place. The stock has recently shown sharp moves, with returns of 9.8% over 7 days and 15.8% over 30 days. It also carries a 27.8% decline over 1 year and a 6.1% decline over 3 years, alongside a 77.3% gain over 5 years. These mixed returns come against a backdrop of ongoing attention on branded fragrance and beauty companies, where investors have...

If you are wondering whether Assurant at around US$233 per share still offers value, you are not alone. The stock’s current price invites a closer look at what you are actually paying for. The share price closed at US$233.39, with returns of a 0.3% decline over 7 days, a 3.5% decline over 30 days and a 1.8% decline year to date, while the 1 year and 3 year returns stand at 12.4% and 88.5% respectively, and the 5 year return is 87.9%. Recent price moves sit against a backdrop of ongoing...